Digest Network Come funziona
Network
/
Società
Ed
Non verificato

Edgewise Therapeutics

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

13 comunicati stampa

Guarda tutti i comunicati
11/03/2025
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
04/03/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Cardiologia
Eventi
Web e Social Network
Edgewise Therapeutics to Present at the Leerink Partners Global Healthcare Conference on March 11, 2025
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
22/01/2025
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
13/01/2025
Web e Social Network
Eventi
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
07/01/2025
Eventi
Web e Social Network
Biotecnologia
Sanità
Farmaceutica
Salute
Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
16/12/2024
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Industria
Eventi
Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
05/12/2024
Scienza
Igiene alimentare
Medicina - Varie
Cardiologia
Biotecnologia
Sanità
Farmaceutica
Salute
Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
26/11/2024
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
07/11/2024
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0
01/10/2024
Eventi
Fiere
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Fonte
Edgewise Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0